ArticleComputational and structural biotechnology journal2020
A deep learning and similarity-based hierarchical clustering approach for pathological stage prediction of papillary renal cell carcinoma.
Article in Computational and structural biotechnology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Deep representation learning for temporal inference in cancer omics: a systematic literature review.Briefings in bioinformatics · 2026Pooled it
- Deep learning model based on CT images to predict Ki-67 expression in renal carcinoma.Oncology letters · 2026Article
- Clinical outcome-guided deep temporal clustering for disease progression subtyping.Journal of biomedical informatics · 2024Article
- Machine Learning of Multi-Modal Tumor Imaging Reveals Trajectories of Response to Precision Treatment.Cancers · 2023Article
- CanMethdb: a database for genome-wide DNA methylation annotation in cancers.Bioinformatics (Oxford, England) · 2023Article
- Omics Data and Data Representations for Deep Learning-Based Predictive Modeling.International journal of molecular sciences · 2022Review
- Characterization of terminal-ileal and colonic Crohn's disease in treatment-naïve paediatric patients based on transcriptomic profile using logistic regression.Journal of translational medicine · 2021Article
- Deep learning for COVID-19 chest CT (computed tomography) image analysis: A lesson from lung cancer.Computational and structural biotechnology journal · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Papillary renal cell carcinoma (pRCC), which accounts for 10-15% of renal cell carcinomas, is the second most frequent renal cell carcinoma. pRCC patient classification is difficult because of disease heterogeneity, histologic subtypes, and variations in both disease progression and patient outcomes. Nevertheless, symptom-based patient classification is indispensable in deciding treatment options. Here we introduce a prediction method for distinguishing pRCC pathological tumour stages using deep learning and similarity-based hierarchical clustering approaches. Differentially expressed genes (DEGs) were identified from gene expression data of pRCC patients retrieved from TCGA. Thirty-three of these genes were distinguished based on expression in early or late stage pRCC using the Wilcoxon rank sum test, confidence interval, and LASSO regression. Then, a deep learning model was constructed to predict tumour progression with an accuracy of 0.942 and area under curve of 0.933. Furthermore, pathological sub-stage information with an accuracy of 0.857 was obtained via similarity-based hierarchical clustering using 18 DEGs between stages I and II, and 11 DEGs between stages III and IV, identified through Wilcoxon rank sum test and quantile approach. Additionally, we offer this classification process as an R function. This is the first report of a model distinguishing the pathological tumour stages of pRCC using deep learning and similarity-based hierarchical clustering methods. Our findings are potentially applicable for improving early detection and treatment of pRCC and establishing a clearer classification of the pathological stages in other tumours.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.